Key result
Circulating adiponectin concentration was positively associated with endothelium-independent vasodilation in healthy subjects, independent of insulin sensitivity.
Cross-Sectional (n=120)
Circulating adiponectin is positively associated with endothelium-independent vasodilation in healthy individuals, independent of insulin sensitivity, but this relationship is lost in those with altered glucose tolerance.
Answers are grounded in this paper and cite their sources.
Association in healthy subjects warrants no practice change; hypothesis-generating for its absence in glucose intolerance.
OBJECTIVE: Adiponectin has been proposed to play important roles in the regulation of energy homeostasis and insulin sensitivity. In experimental studies, adiponectin has also been found to inhibit vascular smooth muscle cell proliferation. Decreased adiponectin levels have been described in patients with coronary artery disease, and circulating adiponectin predicts cardiovascular death in patients with renal failure. Because adiponectin appears to influence both insulin sensitivity and vessel wall physiology, we examined insulin sensitivity and vascular function in relation with circulating adiponectin. RESEARCH DESIGN AND METHODS: We studied brachial artery vascular reactivity (high-resolution external ultrasound) and insulin sensitivity (minimal model) in 68 healthy subjects. Brachial artery vascular reactivity was also determined in 52 patients with altered glucose tolerance: 30 subjects with impaired fasting glucose (IFG) or glucose intolerance (GIT) and 22 patients with type 2 diabetes. RESULTS: Circulating adiponectin concentration was significantly associated with insulin sensitivity (r=0.29, P=0.02) and with fasting serum triglycerides (r=-0.29, P=0.02) in healthy subjects. In the latter, adiponectin levels were positively associated with arterial vasodilation in response to nitroglycerin (endothelium-independent vasodilation [EIVD], r=0.41, P=0.002) but not with flux-induced, endothelium-dependent vasodilation (EDVD) (r=0.007, P=NS). In contrast, EIVD was not significantly associated with adiponectin in subjects with IFG, GIT, or type 2 diabetes (r < or =0.10, P=NS). In a multiple linear regression analysis to predict EIVD in healthy subjects, age (P=0.012), sex (P=0.042), and adiponectin concentration (P=0.045), but not BMI, insulin sensitivity, or fasting triglycerides, contributed to 39% of EIVD variance. CONCLUSIONS: Serum adiponectin concentration appears to be significantly associated with vascular function in apparently healthy humans. This association seems to be independent of its link with insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
Fernández‐Real et al. (2004) conducted a cross-sectional in Healthy and altered glucose tolerance (n=120). Circulating adiponectin was evaluated on Endothelium-independent vasodilation (EIVD) (r=0.41, p=0.002). Circulating adiponectin concentration was positively associated with endothelium-independent vasodilation in healthy subjects, independent of insulin sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: